Article: King Pharmaceuticals to license Skyepharma's delivery technology.

Article: King Pharmaceuticals Announces Completion of Patient Enrollment ...
PR Newswire;  November 3, 2003 ;     700+ words ... ... failure, or damage to the eyes. About Altace(R) Altace(R) is marketed by Monarch Pharmaceuticals ... and Wyeth Pharmaceuticals in the United States and Puerto Rico pursuant to a co-promotion agreement. Altace(R) is indicated for the treatment ...

Article: King Pharmaceuticals Reports FDA Acceptance of Altace(R) ...
PR Newswire;  September 22, 2005 ;     700+ words ... ... for more than seven years. About Altace(R) Altace(R) is marketed by Monarch Pharmaceuticals ... and Wyeth Pharmaceuticals in the United States and Puerto Rico pursuant to a co-promotion agreement. Altace(R) is the leading branded ACE ...

Article: King Pharmaceuticals Announces Jack Nicklaus As Spokesperson For ...
PR Newswire;  October 29, 2001 ;     700+ words ... ... spokesperson for King's product Altace(R) (ramipril), an angiotensin ... enzyme ("ACE") inhibitor. Altace(R) is marketed by Monarch ... Ayerst Laboratories in the United States and Puerto Rico pursuant to ... prnh/20010125/KGLOGO ) Altace(R) was first approved by ...

Article: Recently Reported ALLHAT Trial Does Not Address Benefits of ...
PR Newswire;  December 19, 2002 ;     700+ words ... ... evidence from the HOPE trial, Altace(R) remains the only differentiated ... cigarette smoking, etc.). Altace(R) is marketed by Monarch ... Wyeth, NYSE: WYE) in the United States and Puerto Rico pursuant to ... agreement. When promoting Altace(R), King and Wyeth emphasize ...

Article: King Pharmaceuticals Reports Agreement on Dismissal of ...
PR Newswire;  February 27, 2006 ;     700+ words ... ... Abbreviated New Drug Application. About Altace(R) Altace(R) is marketed by Monarch Pharmaceuticals ... and Wyeth Pharmaceuticals in the United States and Puerto Rico pursuant to a co-promotion agreement. Altace(R) is a leading branded ACE inhibitor ...

Article: King Pharmaceuticals and Skyepharma Announce Licensing Agreement ...
PR Newswire;  May 19, 2003 ;     700+ words ... ... formulation of King's product Altace(R) (ramipril) utilizing ... technology Geomatrix(R). Altace(R) is a patented angiotensin ... inhibitor with net sales in the United States and Puerto Rico totaling ... modified-release formulation of Altace(R) should provide the product ...

Article: ALTACE(R) (Ramipril) Receives New Indication to Reduce ...
PR Newswire;  October 5, 2000 ;     700+ words ... ... received benefit by adding ALTACE 10 mg to their cardiovascular ... of HOPE, we believe that if ALTACE is used in the appropriate ... year. This new indication for ALTACE could significantly transform ... cause of disability in the United States and the number three cause ...